logo
Select company
Select metric
42.29Price to Earnings
VS
Market
20
Sector
25
Industry
21
History
100
$ 7.21Close
$ 3.43 - $ 14.41 52-Week Range
Ticker Information

Ticker

NAGE

Company Name

NIAGEN BIOSCIENCE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NIAGEN BIOSCIENCE INC - Price to Earnings Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NAGE - P/E Historical data
DateMarket CapitalizationNet Income Common StockPrice to Earnings
6/30/2025$ 749.68M$ 17.73M42.29
3/31/2025$ 665.6M$ 14.11M47.19
12/31/2024$ 435.4M$ 8.55M50.92
9/30/2024$ 266.58M$ 1.49M179.51
6/30/2024$ 199.7M$ -1.35M0
3/31/2024$ 289.31M$ -3.53M0
12/31/2023$ 131.04M$ -4.94M0
9/30/2023$ 120.2M$ -6.47M0
6/30/2023$ 123.8M$ -6.5M0
3/31/2023$ 110.2M$ -10.7M0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NIAGEN BIOSCIENCE INC's latest trailing twelve months (TTM) P/E stands at 0.
  • Over the past 5 years, NIAGEN BIOSCIENCE INC's average P/E has been 79.98.
  • The median P/E for NIAGEN BIOSCIENCE INC during this period was 49.06
  • NIAGEN BIOSCIENCE INC reached its highest P/E over the past 5 years at 179.51.
  • The lowest P/E recorded by NIAGEN BIOSCIENCE INC in the same timeframe 42.29

NIAGEN BIOSCIENCE INC's P/E vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

P/E Benchmarks
CompanyP/E
CRMD : CORMEDIX INC 15.77PHAT : PHATHOM PHARMACEUTICALS INC -GYRE : GYRE THERAPEUTICS INC 163.03ANAB : ANAPTYSBIO INC -ZYME : ZYMEWORKS INC -URGN : UROGEN PHARMA LTD -NRIX : NURIX THERAPEUTICS INC -TBPH : THERAVANCE BIOPHARMA INC 48SNDX : SYNDAX PHARMACEUTICALS INC -XNCR : XENCOR INC -

Definition of Price to Earnings

[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.
Market Cap / Net Inc. Cmn.
(=) P/E
P/E for NIAGEN BIOSCIENCE INC is calculated as follows: Market Cap [ $ 295.35M ] / Net Inc. Cmn. [ $ -22.68M ]
(=) P/E [ 0 ]

NAGE - Price to Earnings, Last 5 years

42.29

Minimum

Jun 30, 2025

179.51

Maximum

Sep 30, 2024

79.98

Average

49.06

Median

P/E Benchmark Analysis

The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.54 with a standard deviation of 14.
The following table provides additional summary stats:
P/E in the Market:
filtered constituents2.08K
min0.13
max70.48
average22.54
median18.89
std14